Klinikum Fulda - Hauptstandort
Pacelliallee 4
36043 Fulda
Phone:
0661-84-0
Fax:
0661-84-5013
Mail:
ed.adluf-mukinilk@ofni
- Number of beds: 952
- Number of specialist departments: 29
- Number of inpatient cases: 35.600
- Number of partial inpatient cases: 517
- Number of outpatient cases: 47.676
- Hospital owners: Klinikum Fulda gemeinnützige Aktiengesellschaft
- Type of provider: öffentlich
- Zahn- und Kieferheilkunde, Mund- und Kieferchirurgie
- Allgemeine Chirurgie
- Chirurgie/Schwerpunkt Orthopädie
- Neurochirurgie
- Gefäßchirurgie
- Herzchirurgie
- Urologie
- Frauenheilkunde und Geburtshilfe
- Hals-, Nasen-, Ohrenheilkunde
- Neurologie
- Neurologie/SchwerpunktSchlaganfallpatienten (Stroke units, Artikel 7 § 1 Abs. 3 GKV-SolG)
- Innere Medizin/Schwerpunkt Kardiologie
- Allgemeine Psychiatrie
- Allgemeine Psychiatrie/Tagesklinik (für teilstationäre Pflegesätze)
- Psychosomatik/Psychotherapie
- Psychosomatik/Psychotherapie/Tagesklinik (für teilstationäre Pflegesätze)
- Intensivmedizin/Schwerpunkt Innere Medizin
- Operative Intensivmedizin/Schwerpunkt Chirurgie
- Dialyse, teilstationär
- Radiologie
- Augenheilkunde
- Palliativmedizin
- Innere Medizin/Schwerpunkt Nephrologie
- Innere Medizin/Schwerpunkt Hämatologie und internistische Onkologie
- Innere Medizin/Schwerpunkt Gastroenterologie
- Innere Medizin/Schwerpunkt Pneumologie
- Innere Medizin/Schwerpunkt Rheumatologie
- Pädiatrie
- Neonatologie
Further information
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | yes |
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | yes |
| Bezeichnung | |
| Teilnahme externe Qualitätssicherung | yes |
Diabetes mellitus Typ 1
| Quantity performed | 19 |
| Exception? | No exception |
| Quantity performed | 57 |
| Exception? | No exception |
| Quantity performed | 24 |
| Exception? | No exception |
| Quantity performed | 15 |
| Exception? | No exception |
| Quantity performed | 32 |
| Exception? | No exception |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 57 |
| Quantity forecast year: | 74 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 24 |
| Quantity forecast year: | 19 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 32 |
| Quantity forecast year: | 26 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 15 |
| Quantity forecast year: | 13 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 19 |
| Quantity forecast year: | 16 |
| Examination by state associations? | yes |
| Exemption? | no |
| Result of the examination by the federal state authorities? | no |
| Transitional arrangement? | no |
| No. | Explanation |
|---|---|
| CQ18 | Measures for quality assurance of positron emission tomography in patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma for interim staging after chemotherapy to decide on the continuation of therapy (Amended by resolution of July 15, 2021, see CQ29). |
| CQ25 | Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V |
| CQ30 | Quality assurance guideline for interstitial LDR brachytherapy for low-risk localized prostate cancer (effective January 8, 2021). |
| CQ05 | Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1 |
| CQ22 | Quality assurance measures for interstitial low-dose-rate brachytherapy for the treatment of localised prostate cancer (These QA measures will expire at the end of January 7, 2021). |
| CQ03 | Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules |
| CQ01 | Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm |
| CQ27 | Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR) |
| CQ28 | Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction) |
- Clarifying chat completed: no
- Clarifying chat not completed: no
- No participation in clarifying chat: no
- Notification of non-fulfilment of nursing care not made: yes
| Number | Group |
|---|---|
| 251 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 239 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 198 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
- Accessibility
- Hygiene
- Quality management and risk management
- Complaint management
- Participation emergency care
- Drug commission
Training of employees on AMTS related topics
Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children
Apotheken Handbuch
31.12.2020
Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)
Zentrales QM Handbuch
31.12.2020
Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)
Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)
- Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
- Zubereitung durch pharmazeutisches Personal
- Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
- Patientenindividuelle Zubereitung der totalen parenteralen Ernährung und der Antibiotikazubereitung in der Kinderklinik durch die Apotheke
- Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
Electronic documentation of the administration of drugs
- Fallbesprechungen
- Maßnahmen zur Vermeidung von Arzneimittelverwechslung
- Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
- Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
- Sonstige Konzepte: DokuPik (Bundesverband Deutscher Krankenhausapotheker)
- Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
- Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
- Aushändigung des Medikationsplans
- bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
Job
Explanation
Universitätsmedizin Marburg - Campus Fulda ; Universitäre Lehre Humanmedizin: 2. und 3. klinisches Studienjahr ( 7.-10. Semester) und Praktisches Jahr
FL08 - Editors of scientific journals/textbooks
Explanation
FL06 - Participation in multi-centre phase III/IV studies
Explanation
FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies
Explanation
FL01 - Lectureships / teaching posts at colleges and universities
Explanation
FL05 - Participation in multi-centre Phase I/II studies
Explanation
FL09 - Doctoral supervision
Explanation
FL02 - Lectureships / teaching posts at universities of applied sciences
Explanation
FL04 - Project-related cooperation with colleges and universities
Explanation
Training in other healing professions
HB19 - Nursing professionals
Comment
HB05 - Medical technical radiology assistant (MTRA) (m/f)
Comment
HB07 - Surgical technical assistant (m/f)
Comment
HB12 - Medical technical laboratory assistant (MTLA) (m/f)
Comment
HB15 - Anaesthesia technical assistant (m/f)
Comment
Comment
Praktischer Teil
HB17 - Auxiliary nurse (m/f)
Comment
- Hospital staff
- Number of pharmacists: 12
- Additional staff: 12
Mathilde Purtauf
Patientenfürsprecherin
Pacelliallee 4
36043 Fulda
Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni
Leo Zehkorn (ab November 2021)
Patientenfürsprecher
Pacelliallee 4
36043 Fulda
Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni
Assessorin Bärbel Schwalm
Leiterin Stabsstelle Recht und Compliance
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5130
Mail: ed.adluf-mukinilk@mlawhcs.lebreab
Boris Krah
Leiter Qualitäts- und Risikomanagement
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5131
Mail: ed.adluf-mukinilk@hark.sirob
Heil Stefanie
Leiterin Qualitäts- und Risikomanagement (kommissarisch)
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5131
Mail: ed.adluf-mukinilk@lieh.einafets
Prof. Dr. Roland Radziwill
Direktor Apotheke
Pacelliallee 4
36043 Fulda
Phone: 0661-84-6430
Mail: ed.adluf-mukinilk@lliwizdaR.dnaloR
Mathilde Purtauf
Patientenfürsprecherin
Pacelliallee 4
36043 Fulda
Phone: 0661-84-6652
Mail: ed.adluf-mukinilk@ofni
Ronald Petrovic-Poljak
Pflegedirektor
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5023
Mail: ed.adluf-mukinilk@LDP
Burkhard Bingel
Vorstand Administration
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5017
Mail: ed.adluf-mukinilk@ofni
Priv. Doz. Dr. med. Thomas P. Menzel
Vorstand Krankenversorgung (Vorstandssprecher)
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5011
Mail: ed.adluf-mukinilk@ofni
Priv.-Doz. Dr. med. Thomas Menzel
Vorstand Krankenversorgung
Pacelliallee 4
36043 Fulda
Phone: 0661-84-5011
Mail: ed.adluf-mukinilk@ofni
IK: 260620157
Location number: 772145000
Old location number: 772145000